会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Cyclopentane (ene) oic acid, 2-alkenyl derivatives as therapeutic agents
    • 环戊烷(烯)酸,2-烯基衍生物作为治疗剂
    • US06258844B1
    • 2001-07-10
    • US09194457
    • 1998-11-24
    • Michael E. GarstMichael B. RoofMing F. ChanDavid F. WoodwardRobert M. BurkTodd S. GacSteven W. Andrews
    • Michael E. GarstMichael B. RoofMing F. ChanDavid F. WoodwardRobert M. BurkTodd S. GacSteven W. Andrews
    • A67K31215
    • A61K31/5575C07C405/00Y10S514/913
    • The invention relates to the use of omega chain modified prostaglandins as ocular hypotensive. The derivatives used in accordance with the invention are encompassed by the following structure formula I: wherein the hatched segments represent &agr; bonds; the wavy segment represents an &agr; or &bgr; bond; dashed lines represent a double bond or a single bond; X is selected from the group consisting of —OR and N(R2); Y is=O or represents 2 hydrogen radicals, provided that Y represents 2 hydrogen radicals when X is OH; R is hydrogen or a lower alkyl radical having up to six carbon atoms; R1 is=O or hydroxy; m is 0, 2, 4 or 6, provided that m is not 4 when the wavy segment represents a &bgr; bond; n is 0, 2, 4 or 6; x and y are 0 or 1, provided that x is 1 when y is 0 and y is 1 when x is 0; or 9, 11 and/or 15 ester derivatives of said compound of formula I, e.g. a C1 to C6 alkyl ester derivative; or a pharmaceutically acceptable salt thereof. In a further aspect, the present invention relates to an ophthalmic solution comprising a therapeutically effective amount of a compound of formula (I), wherein the symbols have the above meanings, in admixture with a non-toxic, ophthalmically acceptable liquid vehicle, packaged in a container suitable for metered application.
    • 本发明涉及使用ω-链修饰的前列腺素作为眼压降低。 根据本发明使用的衍生物包括下列结构式I:其中阴影线段代表α键; 波浪段表示α或β键; 虚线表示双键或单键; X选自-OR和N(R2); Y为= O或表示2个氢原子,条件是当X为OH时,Y表示2个氢原子; R是氢或具有至多6个碳原子的低级烷基; R1为= O或羟基; m为0,2,4或6,条件是当波浪段代表β键时m不为4; n为0,2,4或6; x和y为0或1,条件是当y为0时x为1,当x为0时y为1; 或所述式I化合物的9,11和/或15酯衍生物,例如。 C1-C6烷基酯衍生物; 或其药学上可接受的盐。 在另一方面,本发明涉及一种眼用溶液,其包含治疗有效量的式(I)化合物,其中符号具有上述含义,与无毒的眼科可接受的液体载体混合,包装在 适用于计量应用的容器。